Artificial intelligence models have a valuable role to play in each phase of the total testing process.
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Approval for OTC use of a urine drug test that can be performed by non-CLIA facilities could help expand accessibility, expert says.
Using LIMS and no-code solutions can unlock opportunities for efficiency.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
With recent test recalls announced by Universal Medtech and QuidelOrtho, such products now make up one-third of 2023 total recalls listed by the FDA.
New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.
The agency recently sent its own proposed LDTs regulation rule to the White House Office of Information and Regulatory Affairs for review.
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.
Protein levels in the vitreous humor may have the potential to support the diagnosis and staging of neurodegenerative diseases.
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.